Hantson L, De Weerdt W, De Keyser J, Diener H C, Franke C, Palm R, Van Orshoven M, Schoonderwalt H, De Klippel N, Herroelen L
FLOK, Laboratory of Neuromotor Rehabilitation, Katholieke Universiteit leuven, Belgium.
Stroke. 1994 Nov;25(11):2215-9. doi: 10.1161/01.str.25.11.2215.
For detecting therapeutic effect and matching of treatment groups in stroke trials, a scale that meets the clinimetric criteria is of the utmost importance.
The European Stroke Scale consists of 14 items selected for their specificity and their prognostic value. It is designed for patients with middle cerebral artery stroke. Interrater reliability, internal consistency, and time for completion were investigated in 74 patients. Intrarater reliability was studied in 38 patients. To establish concurrent validity, two trials were performed in 20 and 44 patients. The scale was correlated with the MCA Neurological Scale, the Canadian Stroke Scale, the Scandinavian Stroke Scale, the Barthel Index, and the Rankin Scale. Correlations were calculated by means of Spearman's correlation coefficient. The trial in 44 patients also investigated the prognostic validity of the scale for 1-month and 8-month neurological, functional, and handicap status. These data were analyzed by linear regression.
Interrater (kappa value range, 0.62 to 0.85) and intrarater (kappa value range, 0.65 to 1.00) reliability for each item was good, and internal consistency was excellent (Cronbach's alpha coefficient, 0.92). Mean time for completion was 8.2 minutes (range, 4 to 14 minutes). Correlations of the European Stroke Scale with other neurological scales ranged from 0.93 to 0.95. The correlation with the Barthel Index and the Rankin Scale was 0.84 and -0.86. The R2 values for prognostic validity ranged from 0.45 to 0.81 (P < or = .0001).
The European Stroke Scale has been developed according to the clinimetric criteria.
在中风试验中，为检测治疗效果及匹配治疗组，一个符合临床测量标准的量表至关重要。
欧洲中风量表由14个因其特异性和预后价值而选定的项目组成。它是为大脑中动脉中风患者设计的。在74例患者中研究了评定者间信度、内部一致性和完成时间。在38例患者中研究了评定者内信度。为建立同时效度，在20例和44例患者中进行了两项试验。该量表与大脑中动脉神经量表、加拿大中风量表、斯堪的纳维亚中风量表、巴氏指数和Rankin量表进行了相关性分析。相关性通过Spearman相关系数计算。在44例患者中进行的试验还研究了该量表对1个月和8个月神经、功能和残疾状况的预后效度。这些数据通过线性回归进行分析。
每个项目的评定者间（kappa值范围为0.62至0.85）和评定者内（kappa值范围为0.65至1.00）信度良好，内部一致性极佳（Cronbach's alpha系数为0.92）。平均完成时间为8.2分钟（范围为4至14分钟）。欧洲中风量表与其他神经量表的相关性范围为0.93至0.95。与巴氏指数和Rankin量表的相关性分别为0.84和 -0.86。预后效度的R2值范围为0.45至0.81（P≤0.0001）。
欧洲中风量表是根据临床测量标准制定的。
